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Abstract: A short, 9-step, highly enantioselective synthesis of (–)-
erogorgiaene and its C11 epimer is reported. The key stereoche-
mistry controlling steps involve catalytic asymmetric crotylation, 
anionic oxy-Cope rearrangement and cationic cyclization. (–)-
Erogorgiaene exhibited promising antitubercular activity against 
multidrug resistant strains of M. tuberculosis. 
Introduction 
For many years, natural products served as an inspirational 
source for developing new drugs. Now, with antibiotics losing 
their effectiveness at an alarming rate, there is an urgent need to 
find new antibacterial leads to tackle this problem. Diterpenoids 
bearing a serrulatane (biflorane) skeleton exhibited a wide range 
of useful biological properties including promising antimycobac-
terial activity.[1] Selected representatives of serrulatane metabo-
lites found in the marine gorgonian Pseudopterogorgia elisa-
bethae (1-4) and in terrestrial plants, e.g. Mexican evergreen 
shrub Leucophyllum frutescens (5) and Australian Eremophila 
(6), are shown in Figure 1. Inspection of the stereochemical 
elements of these compounds reveals that the diterpenes isolat-
ed from the sea organisms differ from the terrestrial counterparts 
by the relative configuration at C-11. Additionally, these two 
groups of serrulatane diterpenes generally belong to the oppo-
site enantiomeric series, although the levorotatory enantiomer of 
1 was isolated from a brown alga (Dictyota dichotoma).[2]  
The relatively simple structures and potent biological activity of 
serrulatane diterpenes that in many instances is augmented by 
the low abundance and scarcity of supply from their natural 
sources make them attractive synthetic targets for exploring their 
therapeutic potential. However, the lack of functional groups 
near the stereogenic centres in the predominantly hydrocarbon 
serrulatane core represents a significant challenge for stereose-
lective synthesis. The successful strategies for controlling stere-
ochemistry in the total synthesis of this family of diterpenes 
include chiral pool,[3] chiral reagents/chiral substrates,[4] and 
asymmetric catalysis.[5] In the case of erogorgiaene 1, the syn-
thesis usually required 11 steps or more, for a notable exception 
of the 8-step convergent sequence developed by Aggarwal,[4b] 
which also provided access to other three diastereoisomers of 1. 
Recently, we reported on enantioselective synthesis of (-)-
elisabethadione 3, where the key stereochemistry defining steps 
included (i) catalytic asymmetric crotylation, (ii) anionic oxy-Cope 
rearrangement (AOC) and (iii) cationic cyclization.[5d] Herein, we 
present extension of this strategy to a wider range of serrulatane 
diterpenes with a detailed insight into the stereochemistry of the 
AOC. The generality of the method is illustrated by a short, 
highly enantioselective synthesis of both C-11 diastereoisomers 
of erogorgiaene 1 followed by investigation into their activity 
against Mycobacterium tuberculiosis including multidrug re-
sistant strains. 
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Figure 1. Serrulatane metabolites. 
Results and Discussion 
Retrosynthetic analysis of erogorgiaene 1 (Scheme 1) identifies 
α-methylcinnamaldehyde 11b as the starting material, which 
[a] Dr. C. A. Incerti-Pradillos, Dr. M. A. Kabeshov, Dr. P. S. O’Hora, S. 
A. Shipilovskikh, and Prof. Dr. A. V. Malkov 
Department of Chemistry 
Loughborough University 
Loughborough, LE11 3TU, UK  
Fax: +44 (0)1509 22 3925 
E-mail: A. Malkov@lboro.ac.uk  
[b] S. A. Shipilovskikh, Dr. V. A. Drobkova, S. Yu. Balandina and Dr. A. 
E. Rubtsov 
Department of Chemistry 
Perm State University 
Bukireva 15, Perm, 614990, Russia 
 Supporting information for this article is given via a link at the end of 
the document 
FULL PAPER    
 
 
 
 
 
undergoes asymmetric allylation with 10 to afford alcohol 9 
followed by the anionic oxy-Cope rearrangement into 8 that 
installs two out of three stereogenic centers of the serrulatane 
skeleton. Ensuing cationic cyclization after side chain extension 
delivers the final stereogenic center (7). 
 
Scheme 1. Retrosynthetic analysis of erogorgiaene 1. 
Catalytic methods for highly enantio- and diastereoselective 
crotylation of unsaturated aldehydes mediated by chiral Lewis 
bases have been reported from this laboratory and by others.[5d, 
6] Therefore, the initial studies for assessing feasibility of this 
sequence were focused on the stereochemical course of the 
AOC rearrangement and subsequent transformations. The mod-
el experiments were carried out with alcohols syn-9a and anti-14 
that are conveniently synthesized in diastereomerically pure 
form by crotylation of α-methylcinnamaldehyde 11a with Z-
crotyltrichlorosilane 10 and its E-isomer 13, respectively[5d, 6] 
(Scheme 2). The enolate resulting from the rearrangement was 
protonated with MeOH at –78oC and the intermediate aldehyde, 
without isolation, was subjected to Wittig alkenylation to furnish 
15a. Clearly, syn-9a exhibited much better stereoselectivity. 
Note that the AOC is responsible for the formation of C4 and the 
geometry of the alkene (E/Z) in 15a, whereas C11 is formed 
post rearrangement, in the protonation of the enolate.  
The charge-accelerated [3,3] sigmatropic process is likely to 
proceed via a chair-like transition state, however chirality trans-
fer in the AOC is not straightforward and strongly depends on 
the substitution pattern of the substrate.[7] Analysis of the stereo-
chemical course of the AOC is presented in Scheme 3. 
 
Scheme 2. Model studies of anionic oxy-Cope rearrangement.  
In the rearrangement of syn-9a, the two possible transition 
states A and B will result in the respective products 17 and 18 
with a different alkene geometry and, importantly, with the oppo-
site absolute configuration at the benzylic centre. However, the 
TS B is clearly disfavored due to the axial arrangement of the 
three adjacent substituents: the two methyl groups and the 
alkoxide. Therefore, enolate 17 is formed preferentially (17/18 
25:1). Both chair-like transition states C and D resulting from 
anti-14 feature two axial and one equatorial substituent, however 
TS D appears to be much less favourable due to the adverse 
1,3-diaxial interactions between the methyl groups. The ob-
served lack of stereoselectivity in this instance (17’/18’ 3:1) 
suggests that a boat TS might be involved.[7a] 
It is also pertinent to note that to produce the same C-4 enanti-
omer of 17/17’, alcohols syn-9a and anti-14 should come from 
the opposite enantiomeric series (Schemes 2 and 3).  
 
Scheme 3. Stereochemistry of anionic oxy-Cope rearrangement. 
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As a consequence, to enable an efficient transfer of chirality in 
the asymmetric variant of the AOC, it is a prerequisite to employ 
diastereomerically pure 9a since asymmetric crotylation is usual-
ly face-selective and affords syn and anti isomers (9 and 14) 
with the same absolute configuration of the alcohol.[5d] 
Furthermore, E configuration of the double bond in 17 (and 15a) 
is crucial for achieving 1,4-trans tetralin structure 16a in the 
subsequent cationic cyclization (Scheme 2, cf Figure 1), as Z-
alkene 18 appears to favour the respective 1,4-cis tetralin.[5d, 8]  
While the engineered substitution pattern in 9a ensures the high 
stereochemical fidelity in the formation of the C-4 stereogenic 
center during the AOC, formation of the C-11 relies on a face-
selective protonation of the potassium enolate resulting from the 
rearrangement. Methanol quenching at –78 °C furnishes a near-
ly equimolar mixture of isomeric syn-19 and anti-20. Preliminary 
calculations at the semi-empirical level[9] identified two major 
conformations E and F (Scheme 4) of the intermediate enolate 
(modelled as enol). A less than 0.3 kcal/mol energy difference 
between E and F correlates with the observed lack of stereose-
lectivity in the protonation. A brief optimisation of quenching 
conditions under kinetic control revealed that protonation of the 
enolate with a bulkier 2,4,6-tri-tert-butylphenol at –78 °C gave an 
improved 2.5:1 d.r. (Scheme 2). It is worth noting that equilibra-
tion of a 2:1 19/20 mixture with MeONa in MeOH/THF at rt for 12 
h resulted in a 1:1.3 mixture favoring 20. 
 
Scheme 4. Diastereoselectivity of protonation of enolate 17. 
Next, we attempted a racemic variant of the synthesis of erogor-
giaene 1 starting from α-methylcinnamaldehyde 11b (Scheme 5). 
Crotylation of 11b with Z-10 using DMF as a Lewis base activa-
tor furnished alcohol syn-9a in 64% yield, which was then sub-
jected to the AOC. Methanol quenching followed by Wittig chain 
extension afforded methyl ester 15b as a 1:1 mixture of C11 
diastereoisomers in 30% yield (unoptimised). Treatment of 15b 
with methanesulfonic acid in DCM at  –78 °C followed by a slow 
warming to room temperature yielded an inseparable mixture of 
syn/anti and regioisomers 16b/21 in nearly equimolar quantities 
making this route impractical. Note that the problem of control-
ling regioselectivity in the cationic cyclization did not exist in the 
previously reported synthesis of elisabethadione 3 since only 
one position on the aromatic ring was available.[5d] 
Therefore, an appropriate protection strategy was considered 
next. In a revised route (Scheme 6), 2-bromo substituted cin-
namaldehyde 11c was chosen as the substrate, the bromine 
serves as a blocking group to eliminate the issue of regioselec-
tivity in the cationic cyclization. Bromine has a successful record 
of being employed as a protecting group in total synthesis of 
natural products on a large scale;[10] it can be readily removed by 
reduction once it has served its purpose. Provided the debro-
mination could be combined with other reduction process, the 
revised strategy would not affect the overall number of steps in 
the synthesis.  
 
Scheme 5. Model studies towards the synthesis of (±)-erogorgiaene (1). 
The route commenced with the synthesis of 11c by aldol 
condensation of commercially available aldehyde 22 with 
propional (70%). Asymmetric crotylation of 11c with 10 
catalysed by our recently developed bis-N-oxide (–)-12[5d] (2 
mol%) in propionitrile at –60 oC on a 5 mmol scale furnished 
homoallylic alcohol syn-(–)-9c in 72% yield and excellent 99:1 er 
(d.r. > 25:1). The AOC rearrangement was carried out following 
the conditions described for alcohol 9a, except the reaction was 
performed in DME at RT.  Quenching the resulting enolate with 
2,4,6-tri-tert-butylphenol at –78 °C gave a 2:1 ratio of C-11 
diastereoisomers. To minimise manipulation of the oxidation-
prone aldehyde and to avoid epimerisation at C-11, the crude 
aldehyde was subjected to Horner-Wadsworth-Emmons 
alkenylation conditions[11] to furnish unsaturated ester 15c (81% 
over 2 steps). The diastereoisomers were not separable at this 
point therefore the synthesis continued with the mixture. Ester 
15c was submitted to the cationic cyclisation with MeSO3H to 
produce trans-tetraline 16c in 83% yield and good 
stereoselectivity (dr 14:1). With all the stereocentres in place, 
the next task was to reduce the unsaturated ester to the 
saturated alcohol and remove Br from the aromatic ring. After 
some experimentation it was found that continuous flow 
hydrogenation in methanol using H-cube (2.0 mL/min, 20 bar, 40 
oC, 4 h) equipped with a 10% Pd/C catalyst cartridge 
accomplished both the double bond reduction and 
debromination. The solvent was replaced for DCM and the 
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saturated ester was reduced with DIBAL-H into primary alcohol 
7 in 70% overall yield. Preparative HPLC separation of the 
diastereoisomers furnished pure (–)-7 and its C-11 epimer (–)-7a. 
Dess-Martin oxidation of (–)-7 led to the respective aldehyde in 
84% yield. Finally, Wittig alkenylation afforded (–)-erogorgiaene 
1 (dr 12:1) in 80% yield exhibiting optical rotation [α]D = –25.5 (c 
0.52, CHCl3) that is in agreement with the value for the natural 
product isolated from a brown alga (Dictyota dichotoma): [α]D = –
28.0 (c 0.05, CHCl3)[2] and the absolute value of the 
dextrorotatory enantiomer from Pseudopterogorgia elisabethae: 
[α]D = +24.4 (c 3.2, CHCl3).[1a] Synthesis of the C-11 epimer (–)-
1a (dr 7:1) from the respective alcohol (–)-7a was completed 
through the same two-step sequence. 
According to an earlier report,[1a] (+)-erogorgiaene 1 exhibited 
promising activity against Mycobacterium tuberculiosis H37Rv 
(96% growth inhibition at 12.5 µg/mL). Due to the minute quanti-
ties of the isolated material, it has not been further investigated. 
C-11 epimer (–)-1a has the same relative and absolute configu-
ration as (–)-leubethanol 5, which showed a potent activity 
against both drug-sensitive and multidrug resistant (MDR) 
strains at minimal inhibitory concentrations (MIC) in the range of 
6.25-12.5 µg/mL.[12] Therefore, with the two diastereoisomers (–
)-1 and (–)-1a in hand, we next evaluated their antitubercular 
activity against two clinical isolates of M. tuberculosis, one of 
which showed sensitivity to isoniazid and rifampicin, the first-line 
anti-TB drugs, the other exhibited multidrug resistance. Selected 
data are presented in Table 1. 
Table 1. Antimycobacterial activity of (–)-1 and (–)-1a 
 
Entry Compound 
MIC (µg/mL) 
Susceptible to 
TB drugs 
MDR Strain 
1 (–)-1 31,25 125,0 
2 (–)-1a 62,5 250,0 
 
The results revealed that (–)-1 was twice as active as its C-11 
epimer (–)-1a against both TB strains. Comparison with the 
literature data for erogorgiaene 1 indicates that the dextrorotato-
ry enantiomer (+)-1 isolated from the octocoral Pseudopterogor-
gia elisabethae showed somewhat higher activity than its enan-
tiomer (–)-1 synthesised in this work. High potency of (–)-
leubethanol 5 seems to indicate the importance of the hydroxyl 
group in the position 8 of the aromatic ring for antitubercular 
activity. It is worth noting that the both C-11 epimers induced 
growth inhibition of the MDR strain and can serve as leads for 
further development. 
 
  
Scheme 6. Asymmetric total synthesis of (–)-1 and its C11 epimer  (–)-1a (ArOH = 2,4,6-(t-Bu)3C6H2OH). 
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Conclusions 
A short, 9-step synthesis of natural (–)-erogorgiaene (10.5% 
overall yield) and its C-11 epimer from a commercially available 
precursor has been accomplished though a sequence of simple 
transformations. The key reactions for introducing stereogenic 
centers include (i) highly enantioselective catalytic crotylation, (ii) 
anionic oxy-Cope rearrangement and (iii) cationic cyclisation. In 
the latter instance, protection strategy was seamlessly integrat-
ed into the synthesis without altering the number of steps. The 
compounds showed promising activity against clinical isolates of 
M. tuberculosis including multidrug resistant strain. Ready ac-
cess to α-methyl cinnamaldehydes with various substitution 
patterns in the aromatic ring opens the door to the synthesis of 
natural and unnatural analogues of these diterpenes for biologi-
cal evaluation. 
Experimental Section 
General Methods and Materials.  
The NMR spectra were recorded in CDCl3, 1H at 400 MHz and 13C at 
100.6 MHz with chloroform-d1 (δ 7.26, 1H; δ 77.0, 13C) as internal stand-
ard unless otherwise indicated. Various 2D-techniques and DEPT exper-
iments were used to establish the structures and to assign the signals. 
The IR spectra were recorded in KBr disc unless otherwise indicated. 
The mass spectra were recorded in a positive or negative ion mode using 
electrospray ionisation (ESI) from methanol or acetonitrile. All reactions 
were performed under an atmosphere of dry, oxygen-free nitrogen in 
oven-dried glassware. Yields are given for isolated products showing one 
spot on a TLC plate and no impurities detectable in the NMR spectrum. 
The identity of the products prepared by different methods was checked 
by comparison of their NMR, IR, and MS data and by the TLC behavior. 
All chromatographic manipulations used silica gel as the absorbent. 
Reactions were monitored by thin layer chromatography (TLC) on alumi-
num backed plates with Merck Kiesel 60 F254 silica gel. TLCs were 
either visualized by UV radiation at a wavelength of 254 nm, or stained 
by exposure to an ethanolic solution of phosphomolybdic acid or potassi-
um permanganate aqueous solution, following by charring where appro-
priate. Purification by column chromatography was carried out using 
Merck Kiesel 60 H silica adsorbent. All solvents and reagents for the 
reactions were of reagent grade and were dried and distilled under 
nitrogen immediately before use as follows: tetrahydrofuran was distilled 
under a nitrogen atmosphere from the sodium/benzophenone ketyl 
radical, propionitrile and dichloromethane were freshly distilled from CaH2. 
Petroleum ether refers to the fraction boiling in the range 40-60 °C. 
Synthesis of Z-crotyltrichlorosilane 10 and catalyst 12 was described by 
us earlier;[5b] literature protocols were used for synthesising known alde-
hydes 11a[13] and 16[14] 
Asymmetric synthesis of (–)-erogorgiane (1) and its C-11 epimer 
(1a) by a revised strategy. 
(E)-3-(2-bromo-3-methylphenyl)-2-methylacrylaldehyde (11c). A 2M 
solution of NaOH (1.9 mL, 3.8 mmol, 1 eq.) was added dropwise to a 
solution of benzaldehyde 16 (750 mg, 3.8 mmol, 1 eq.) and propanal 
(0.50 mL, 5.7 mmol, 1.5 eq.) in MeOH (15 mL), at rt. The reaction was 
allowed to stir at 50 °C overnight. After that time it was quenched with 
NH4Cl and then extracted with DCM (3 x 50 mL). The combined organic 
layers were dried over Na2SO4 and concentrated in vacuo to yield cin-
namaldehyde 11b (630 mg, 70% yield). 1H NMR (400 MHz, CDCl3): δH 
1.92 (s, 3H); 2.47 (s, 3H); 7.20-7.22 (m, 1H); 7.25-7.27 (m, 2H); 7.50 (s, 
1H); 9.69 (s, 1H); 13C NMR (100 MHz, CDCl3): δC 10.7 (CH3), 23.6 (CH3), 
126.6 (C), 126.7 (CH), 127.8 (CH), 131.2 (CH), 135.5 (C), 139.1 (C), 
139.5 (C), 149.1 (CH), 195.3 (CH); IR: ν 3049, 2954, 2922, 2819, 2710, 
1686, 1629, 1572, 1445, 14411, 1385, 1355, 1264, 1186, 1027, 1005, 
935, 866, 834, 789, 771, 723, 681 cm-1; HRMS (ESI) 239.0054 and 
241.0034 (C11H1179BrO and C11H1181BrO [M+H]+ requires 239.0066 and 
241.0046). 
(−)-(3R,4S,E)-1-(2-bromo-3-methylphenyl)-2,4-dimethlhexa-1,5-dien-
3-ol (9c). A 100 mL round bottom flask fitted with a magnetic stirring bar 
was flame-dried, evacuated and backfilled with N2. The flask was 
charged with 30 mL of dry propionitrile and successively with a solution 
of bis-N-oxide (−)-12 (80.4 mg, 0.1 mmol, 2 mol%), aldehyde 11b (1.25 g, 
5.2 mmol, 1 eq.) and Hünig's base (1.8 mL, 10.3 mmol, 2 eq.) in 1 mL of 
dry propionitrile each. The solution was cooled at −60 °C and a solution 
of Z-crotyltrichlorosilane 10 (1.7 g, 8.9 mmol, 1.7 eq.) in 1 mL of dry 
propionitrile was added dropwise to the reaction mixture. The mixture 
was stirred at this temperature for two days.  After that time, it was 
quenched with a saturated solution of NaHCO3 (10 mL), washed with 20 
mL of NaHCO3 and extracted with DCM (3 x 60 mL). Combined organic 
layers were dried over Na2SO4 and solvent was removed in vacuo. Flash 
chromatography on silica with a gradient eluent system (100% hexane to 
95:5, hexane/ethyl acetate) afforded the target homoallylic alcohol (−)-9b 
as a colourless oil (1.10 g, 72 % yield). 1H NMR (400 MHz, CDCl3): δH 
1.13 (d, J = 6.8 Hz, 3H); 1.70 (s, 3H); 1.73 (sbroad, 1H); 2.43 (s, 3H); 2.53 
(q, J = 6.8 Hz, 1H); 4.08 (d, J = 6.4 Hz, 1H); 5.06-5.15 (m, 2H); 5.83-5.91 
(m, 1H); 6.53 (s, 1H); 7.04-7.06 (m, 1H); 7.11-7.17 (m, 2H); 13C NMR 
(100 MHz, CDCl3): δC 13.9 (CH3), 14.4 (CH3), 23.7 (CH3), 41.4 (CH), 80.0 
(CH), 114.7 (CH2), 126.3 (CH), 126.7 (C), 127.1 (CH), 128.2 (CH), 128.9 
(CH), 138.3 (C), 138.3 (C), 139.5 (C), 140.9 (CH); IR: ν3412, 3069, 2975, 
2923, 2870, 1640, 1586, 1463, 1449, 1401, 1379, 1228, 1107, 1024, 913, 
791, 767, 725 cm-1; HRMS (ESI) 400.9666 and 402.9651 (C15H1979BrO 
and C15H1981BrO [M+Ag]+ requires 400.9665 and 402.9644).; Chiral 
HPLC (Chiralpak IA-3, hexane/2-propanol = 98:2, 0.75 mL/min, UV 
detection at 225 nm) showed 99:1 er (tR = 19.3 min (major), tS = 20.8 min 
(minor)). [α]D25 = −27 (c 6.5, CHCl3).  
In a racemic variant, Z-crotyltrichlorosilane 9c (1.0 g, 5.00 mmol) was 
added to a solution of 11c (75 mg, 0.31 mmol, 1 eq.) in DMF (5 mL) and 
Hünig’s base (108 µL, 0.62 mmol, 2 eq.) under N2 atmosphere. The 
reaction mixture was stirred and monitored by TLC until completion. Then 
it was quenched with saturated NaHCO3 (10 mL) and extracted with ethyl 
acetate (3 x 20 mL). The organic layers were dried over Na2SO4 and 
concentrated in vacuo. Flash chromatography on silica with a gradient 
eluent system (100% hexane to 95:5, hexane/ethyl acetate) afforded the 
target homoallylic alcohol (±)-9c as a colourless oil (78 mg, 85 %). 
(2E,4R,5S,7E)-ethyl 5-(2-bromo-3-methylphenyl)-4-methylnona-2,7-
dienoate (15c). A 30% suspension of KH in mineral oil (2.2 g, 55.5 mmol, 
15 eq.) was washed with anhydrous DME (3 x 10 mL). Anhydrous DME 
(45 mL) was added to the KH. Alcohol (−)-9c (1.10 g, 3.7 mmol, 1 eq.) 
and 18-crown-6 (0.97 g, 3.7 mmol, 1 eq.) were successively added to the 
solution and the mixture was stirred for two days at rt. The solution was 
cooled to −78 °C and quenched with a 1M solution of 2,4,6-tri-tert-
butylphenol in dry DME (7eq). The solution was poured into a saturated 
solution of NH4Cl (50 mL) and extracted with DCM (3 x 50 mL). The 
combined organic layers were dried over Na2SO4 and concentrated in 
vacuo. The resulting crude aldehyde obtained as a yellow oil was used 
immediately in the next step. 
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LiCl (186.5 mg, 4.44 mmol, 1.2 eq.) was weighted in a 50 mL flame-dried 
round bottom flask. The flask was evacuated and backfilled with N2. Dry 
CH3CN (10 mL) was added followed by a solution of Hünig's base (0.8 
mL, 4.44 mmol, 1.2 eq.) and triethyl phosphonoacetate (0.9 mL, 4.44 
mmol, 1.2 eq.) in 2 mL of dry CH3CN each. After stirring the mixture for 5 
minutes, the crude aldehyde (3.7 mmol, 1 eq.) in 2 mL of anhydrous 
CH3CN was added dropwise. The reaction mixture was stirred overnight 
at rt and after that time it was quenching with a saturated solution of 
NH4Cl (20 mL). The mixture was extracted with DCM (3 x 50 mL), the 
organic phases dried over Na2SO4 and the solvents removed under 
reduced pressure. The crude mixture was purified by flash column chro-
matography on silica eluting with a gradient system (100% petroleum 
ether to 5:1 petroleum ether/ethyl acetate) to yield 15c (dr 2:1) as a 
colourless oil (1.1 g, 81% yield over two steps).  
Major isomer (taken as a mixture): 1H NMR (400 MHz, CDCl3): δH 1.01 (d, 
J = 6.8Hz, 3H); 1.27 (t, J = 6.8 Hz, 3H); 1.53 (d, 6.4Hz, 3H); 2.37-3.33 (m, 
2H); 2.43 (s, 3H); 2.68-2.71 (m, 1H); 3.49-3.53 (m, 1H); 4.14-4.23 (m, 
2H); 5.11-5.41 (m, 2H); 5.74 (d, J = 15.6Hz, 1H); 6.92-7.01 (m, 2H); 7.06-
7.17 (m, 2H).  
Minor isomer (taken as a mixture): 1H NMR (400 MHz, CDCl3): δH 0.91 (d, 
J = 6.4Hz, 3H); 1.31 (t, J = 7.2 Hz, 3H); 1.49 (d, J = 6.4Hz, 3H); 2.37-3.33 
(m, 2H); 2.44 (s, 3H); 2.49-2.53 (m, 1H); 3.38-3.41 (m, 1H); 4.14-4.23 (m, 
2H); 5.11-5.41 (m, 2H); 5.82 (d, J = 14.8Hz, 1H); 6.92-7.01 (m, 2H); 7.06-
7.17 (m, 2H). 
(R,E)-ethyl 4-((1S,4R)-8-bromo-4,7-dimethyl-1,2,3,4-tetrahydro-
naphthalen-1-yl)pent-2-enoate (16c). Methanesulfonic acid (0.37 mL, 
5.7 mmol, 3 eq.) was added to a solution of 15c (693 mg, 1.9 mmol, 1 
eq.) in CHCl3 (3 mL) and the reaction mixture was stirred at 40 °C for two 
days. The reaction was quenched with saturated NaHCO3 (5 mL) and 
extracted with CH2Cl2 (3 x 20 mL).  The combined organic layers were 
dried over Na2SO4 and concentrated in vacuo. Purification by column 
chromatography on silica (eluting with 95:5 petroleum ether/ethyl ace-
tate) gave the title compound 16c (dr 2:1) as a pale yellow oil (570 mg, 
83% yield);  
Major isomer (taken as a mixture): 1H NMR (400 MHz, CDCl3): δH 0.89 (d, 
J = 6.8Hz, 3H); 1.21-1.31 (m, 6H); 1.74-1.95 (m, 4H); 2.38 (s, 3H); 2.74-
2.79 (m, 1H); 3.04-3.09 (m, 1H); 3.49-3.53 (m, 1H); 4.12-4.4.21 (m, 2H); 
5.74 (dd, J = 16, 1.6Hz, 1H); 7.06-7.12 (m, 3H); 13C NMR (100 MHz, 
CDCl3): δC 14.2 (CH3), 14.2 (CH3), 16.9 (CH3), 21.5 (CH2), 22.3 (CH), 
24.2 (CH3), 29.2 (CH2), 32.2 (CH), 39.6 (CH), 41.7 (CH), 60.1 (CH2), 
120.0 (CH), 125.4 (CH), 128.2 (CH), 136.1 (C), 137.8 (C), 143.4 (C), 
153.3 (CH), 166.8 (C).  
Minor isomer (taken as a mixture): 1H NMR (400 MHz, CDCl3): δH 0.90 (d, 
J = 6.8Hz, 3H); 1.15 (d, J = 7.2Hz, 3H); 1.21-1.31 (m, 3H); 1.74-1.95 (m, 
4H); 2.41 (s, 3H); 2.74-2.79 (m, 1H); 2.97-3.00 (m, 1H); 3.40-3.44 
(m,1H); 4.12-4.21 (m, 2H); 5.64 (dd, J = 15.6, 1.6Hz, 1H), 6.79 (dd, J = 
15.6, 6.4Hz, 1H); 7.06-7.07 (m, 2H); 13C NMR (100 MHz, CDCl3): δC 14.2 
(CH3), 14.3 (CH3), 16.9 (CH3), 21.1 (CH2), 22.6 (CH), 24.2 (CH3), 28.5 
(CH2), 31.8 (CH), 40.0 (CH), 42.7 (CH), 60.0 (CH2), 120.0 (CH), 125.7 
(CH), 128.4 (CH), 136.0 (C), 138.1 (C), 143.1 (C), 152.6 (CH), 166.6 (C). 
(−)-(R)-4-((1S,4R)-4,7-dimethyl-1,2,3,4-tetrahydronaphthalen-1-
yl)pentan-1-ol (7) and (−)-(S)-4-((1S,4R)-4,7-dimethyl-1,2,3,4-
tetrahydronaphthalen-1-yl)pentan-1-ol (7a). A solution of unsaturated 
ester 16c (458 mg, 1.36 mmol, 1 eq.) in MeOH (35 mL) was circulated for 
4 h through an H-Cube reactor (set at 2.0 mL/min, 20 bar, 40 °C) 
equipped with a cartridge containing catalyst 10% Pd/C. Analysis of an 
aliquote taken from the mixture showed that hydrogenation of the double 
bond and debromination were complete. The solvent was removed in 
vacuo, the residue was dissolved in anhydrous CH2Cl2 (20 mL) and 
cooled to −78 °C. DIBAL, 1M in hexanes (2.2 mL, 2.2 mmol), was added 
and the solution was allowed to warm to room temperature and stirred 
overnight. The reaction was quenched with MeOH (10 mL), 5M HCl (15 
mL) and extracted with CH2Cl2 (3x30 mL). The organic layer were com-
bined, dried over Na2SO4 and concentrated in vacuo. The crude reaction 
mixture was filtered through a pad of silica. Removal of solvent in vacuo 
afforded product 7 (dr 2:1) as a colourless oil (235 mg, 70 %). The dia-
stereoisomers 11-epi-7a and 7 were separated in order of elution by 
preparative HPLC (Dynmax-60Å, hexane/2-propanol = 98:2, 5 mL/min, 
UV detection at 220 nm).  
Major isomer (−)-7 (104 mg): 1H NMR (400 MHz, CDCl3): δH 0.65 (d, J = 
5.2Hz, 3H); 1.26 (d, J = 5.6Hz, 3H); 1.31-1.38 (m, 3H); 1.61-1.70 (m, 3H); 
1.78-1.84 (m, 1H); 1.90-1.95 (m, 1H); 2.13-2.16 (m, 1H); 2.30 (s, 3H); 
2.71-2.75 (m, 1H); 2.87-2.91 (m, 1H); 3.70 (t, J = 5.2Hz, 2H); 6.95 (d, J = 
6.4Hz, 1H); 7.03 (s, 1H); 7.14 (d, J = 6Hz, 1H); 13C NMR (100 MHz, 
CDCl3): δC 14.5 (CH3), 21.1 (CH3), 21.5 (CH2), 21.8 (CH3), 31.1 (CH2), 
31.6 (CH2), 32.8 (CH), 37.1 (CH), 41.6 (CH), 63.4 (CH2), 126.0 (CH), 
126.4 (CH), 128.0 (CH), 134.7 (C), 139.6 (C), 140.3 (C); IR: ν 3343, 2928, 
2869, 1497, 1455, 1376, 1058, 812 cm-1; HRMS (ESI) 353.1037 
(C17H26O107Ag [M]+ required 353.1029). [α]D25 = −54.5 (c 1.02, CHCl3); lit. 
for (+)-7 [α]D25 = +36.5 (c 0.81, CHCl3).[5c] 
Minor isomer (–)-7a (65 mg): 1H NMR (400 MHz, CDCl3): δH 1.03 (d, J = 
6.8Hz, 3H); 1.28 (d, J = 6.8Hz, 3H); 1.33-1.39 (m, 2H); 1.47 (sbroad, 1H); 
1.55-1.60 (m, 3H); 1.89-1.94 (m, 2H); 2.08-2.13 (m, 1H); 2.32 (s, 3H); 
2.75-2.81 (m, 2H); 3.48-3.56 (m, 2H); 6.96 (d, J = 8Hz, 1H); 7.04 (s, 1H); 
7.15 (d, J = 8Hz, 1H); 13C NMR (100 MHz, CDCl3): δC 140.3 (C), 139.6 
(C), 134.6 (C), 128.2 (CH), 126.8 (CH), 126.2 (CH), 63.1 (CH2), 43.7 
(CH), 36.9 (CH), 32.7 (CH), 31.2 (CH2), 31.1 (CH2), 27.3 (CH2), 22.2 
(CH2), 22.1 (CH3), 21.1 (CH3), 18.2 (CH3); IR: ν 3343, 2928, 2869, 1497, 
1455, 1376, 1058, 812 cm-1; HRMS (ESI) 353.1037 (C17H26O107Ag [M]+ 
required 353.1029). [α]D25 = −32.9 (c 0.41, CHCl3). [α]D25 = −54.5 (c 1.02, 
CHCl3); lit. for (+)-7 [α]D25 = +36.5 (c 0.81, CHCl3).[5c] 
(−)-(1R,4S)-1,6-dimethyl-4-((R)-6-methylhept-5-en-2-yl)-1,2,3,4-
tetrahydronaphthalene. (–)-Erogorgiaene (1) 
Dess-Martin periodinane (1.5 eq.) was weighted in a 25 mL flame-dried 
round bottom flask. The vessel was evacuated and backfilled with N2 
before being charged with alcohol 7 (104 mg, 1 eq.) in 5 mL of DCM. The 
reaction was allowed to stir at room temperature for 2 hours. The solvent 
was partially removed in vacuo and the crude mixture was directly puri-
fied by flash column chromatography on silica using a 95:5 mixture of 
petroleum ether/ethyl acetate as an eluent. After removal of solvent in 
vacuo, the resulting aldehyde as pale yellow oil (86 mg, 84%) was used 
in the next step.  
nBuLi, 1.6M solution in hexane (0.5 mL, 0.81 mmol, 3 eq.), was added 
dropwise to a solution of isopropyltriphenylphosphonium iodide (385.2 
mg, 0.89 mmol) in anhydrous THF (3 mL) at 0 °C under N2. The mixture 
was stirred for 1 h and then a solution of the aliphatic aldehyde from the 
step above (65 mg, 1.3 mmol) in THF (15 mL) was added. The solution 
was allowed to stir at the same temperature for 30 minutes before warm-
ing to rt and heating at reflux for a further 2 h. After cooling, the reaction 
mixture was quenched with saturated NH4Cl (5 mL) and extracted with 
DCM (3 x 20 mL). The organic layers were combined, dried over Na2SO4 
and concentrated in vacuo. Purification by column chromatography on 
silica (10:1 petroleum ether/ethyl acetate) gave (–)-erogorgiaene 1 as a 
colourless oil (58 mg, 80 %, or 67% over two steps). 1H NMR (400 MHz, 
CDCl3): δH 0.66 (d, J = 6.8 Hz, 3H); 1.29 (d, J = 6.8 Hz, 3H); 1.32-1.41 (m, 
2H); 1.45-1.57 (m, 2H); 1.67 (s, 3H); 1.75 (s, 3H); 1.80-1.87 (m, 1H); 
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1.91-1.97 (m, 1H); 2.04-2.19 (m, 3H); 2.33 (s, 3H); 2.72-2.76 (m, 1H); 
2.88-2.93 (m, 1H); 5.20 (tm, J = 6.8 Hz, 1H); 6.97 (d, J = 8 Hz, 1H); 7.05 
(s, 1H); 7.16 (d, J = 8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δC14.5 (CH3), 
17.7 (CH3), 21.1 (CH3), 21.5 (CH2), 21.8 (CH3), 25.7 (CH3), 26.3 (CH2), 
31.8 (CH2), 32.8 (CH), 35.2 (CH2), 36.9 (CH), 41.4 (CH), 124.9 (CH), 
126.0 (CH), 126.4 (CH), 128.1 (CH), 131.2 (C), 134.7 (C), 139.9 (C), 
140.4 (C); IR: ν  2959, 2924, 2853, 1613, 1497, 1452, 1376, 1320, 1109, 
1039, 983, 881, 811 cm-1; HRMS (ESI) 377.1390 and 379.1386 
(C20H30107Ag [M+Ag]+ requires 377.1393 and C20H30109Ag [M+Ag]+ re-
quires 379.1390). [α]D25 = −25.5 (c 0.52, CHCl3); lit. [α]D25 = −28.0 (c 0.05, 
CHCl3);[2] lit. for (+)-1: [α]D25 = +24.4 (c 3.20, CHCl3);[1a] [α]D25 = +23.2 (c 
0.75, CHCl3);[3c] [α]D25 = +69.1 (c 0.77, DCM);[4b] [α]D25 = +40.6 (c 0.14, 
CHCl3);[5a] [α]D25 = +21.4 (c 0.14, CHCl3).[5c] 
(−)-(1R,4S)-1,6-dimethyl-4-((S)-6-methylhept-5-en-2-yl)-1,2,3,4-
tetrahydronaphthalene (1a).  
Diastereoisomer (–)-1a was obtained from (–)-7a using the same se-
quence as described for (–)-1 as a colourless oil (15 mg, 30% from 7a): 
1H NMR (400 MHz, CDCl3): δH 1.00 (d, J = 6.8 Hz, 3H); 1.23-1.27 (m, 
7H); 1.55 (s, 3H); 1.66 (s, 3H); 1.80-2.00 (m, 4H); 2.07-2.12 (m, 2H); 2.30 
(s, 3H); 2.73-2.77 (m, 2H); 4.98 (t, J = 7.4 Hz, 1H); 6.94 (m, 1H); 7.03 (s, 
1H); 7.13 (d, J = 8 Hz, 1H); 13C NMR (100 MHz, CDCl3): δC 17.6 (CH3), 
18.1 (CH3), 21.1 (CH3), 22.2 (CH3), 22.4 (CH2), 25.7 (CH3), 26.3 (CH2), 
31.4 (CH2), 31.5 (CH2), 32.7 (CH), 36.2 (CH), 43.8 (CH), 125.0 (CH), 
126.1 (CH), 126.7 (CH), 128.4 (CH), 131.2 (C), 134.5 (C), 139.7 (C), 
140.2 (C). IR: ν 2959, 2924, 2853, 1613, 1497, 1452, 1376, 1320, 1109, 
1039, 983, 881, 811 cm-1; HRMS (ESI) 377.1390 and 379.1386 
(C20H30107Ag [M+Ag]+ requires 377.1393 and C20H30109Ag [M+Ag]+ requi-
res 379.1390). [α]D25 = −25.3 (c = 0.3, CHCl3); lit. for (+)-1a: [α]D22 = 
+55.2 (c 0.83, DCM).[4b] 
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